Vontobel Holding Ltd. Vir Biotechnology, Inc. Transaction History

Vontobel Holding Ltd.

  • $29.2 Billion
  • Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 57,446 shares of VIR stock, worth $610,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,446
Previous 44,935 27.84%
Holding current value
$610,650
Previous $399,000 7.77%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$7.26 - $10.7 $90,829 - $133,867
12,511 Added 27.84%
57,446 $430,000
Q2 2024

Aug 13, 2024
SELL
$7.63 - $12.66 $15,061 - $24,990
-1,974 Reduced 4.21%
44,935 $399,000
Q1 2024

May 10, 2024
SELL
$8.6 - $11.9 $5,934 - $8,211
-690 Reduced 1.45%
46,909 $475,000
Q4 2023

Jun 03, 2024
SELL
$7.76 - $10.29 $24,987 - $33,133
-3,220 Reduced 6.34%
47,599 $478,000
Q4 2023

Jan 29, 2024
SELL
$7.76 - $10.29 $24,987 - $33,133
-3,220 Reduced 6.34%
47,599 $478,000
Q3 2023

Jun 03, 2024
BUY
$9.14 - $24.62 $225,355 - $607,030
24,656 Added 94.24%
50,819 $476,000
Q3 2023

Oct 10, 2023
BUY
$9.14 - $24.62 $225,355 - $607,030
24,656 Added 94.24%
50,819 $476,000
Q2 2023

Jun 03, 2024
SELL
$23.2 - $27.29 $48,418 - $56,954
-2,087 Reduced 7.39%
26,163 $641,000
Q2 2023

Jul 24, 2023
SELL
$23.2 - $27.29 $48,418 - $56,954
-2,087 Reduced 7.39%
26,163 $641,000
Q1 2023

Jun 03, 2024
SELL
$22.26 - $30.85 $415,349 - $575,630
-18,659 Reduced 39.78%
28,250 $657,000
Q1 2023

Apr 12, 2023
SELL
$22.26 - $30.85 $94,916 - $131,544
-4,264 Reduced 13.11%
28,250 $657,000
Q4 2022

Feb 14, 2023
SELL
$19.96 - $28.22 $121,077 - $171,182
-6,066 Reduced 15.72%
32,514 $822,000
Q3 2022

Nov 04, 2022
BUY
$18.26 - $31.1 $26,221 - $44,659
1,436 Added 3.87%
38,580 $744,000
Q2 2022

Jul 27, 2022
SELL
$19.08 - $26.7 $121,940 - $170,639
-6,391 Reduced 14.68%
37,144 $966,000
Q1 2022

May 13, 2022
BUY
$21.19 - $40.01 $264,853 - $500,084
12,499 Added 40.27%
43,535 $1.13 Million
Q4 2021

Feb 14, 2022
SELL
$30.97 - $54.03 $38,712 - $67,537
-1,250 Reduced 3.87%
31,036 $1.26 Million
Q3 2021

Oct 29, 2021
BUY
$34.9 - $54.54 $265,065 - $414,231
7,595 Added 30.76%
32,286 $1.41 Million
Q2 2021

Aug 06, 2021
SELL
$38.75 - $51.0 $66,456 - $87,465
-1,715 Reduced 6.49%
24,691 $1.17 Million
Q1 2021

May 11, 2021
SELL
$26.34 - $83.07 $429,473 - $1.35 Million
-16,305 Reduced 38.18%
26,406 $1.35 Million
Q4 2020

Feb 12, 2021
BUY
$25.51 - $43.38 $1.09 Million - $1.85 Million
42,711 New
42,711 $1.14 Million

Others Institutions Holding VIR

# of Institutions
215
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.41B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email